(4R,12aS)-7-(benzyloxy)-9-bromo-4-methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione CAS: 1206102-10-4
![BK75M8 | 1206102-10-4 | (4R,12aS)-7-(benzyloxy)-9-bromo-4-methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione](https://qncdn.chemcd.cn/alchemypharm/1206102-10-4.png "BK75M8 | 1206102-10-4 | (4R,12aS)-7-(benzyloxy)-9-bromo-4-methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione")
| Product Parameters | |
|---|---|
| Catalog No. | BK75M8 |
| CAS.RN | 1206102-10-4 |
| Molecular Formula | C19H19BrN2O4 |
| Molecular Weight | 419.27 g/mol |
| Purity | NLT 98% |
Product Overview
This product is a structurally complex pharmaceutical intermediate, belonging to the key precursors in the synthesis of nucleoside analogues. It is widely used in the research and development and production of innovative drugs such as antiviral and antitumor drugs. It possesses a well-defined stereochemical structure and a specific combination of functional groups, making it suitable for key intermediate steps in multi-step synthetic routes. It can meet diverse needs in research and development, small-scale testing, pilot-scale production, and large-scale production, and is an important raw material for constructing novel heterocyclic compounds.
Applications
- Nucleoside analogue synthesis
- Antiviral drug intermediate development
- Antitumor drug process optimization
- Custom synthesis of heterocyclic compounds
- Support for innovative drug R&D projects
Quality & Supply Capability
English name: (4R,12aS)-7-(benzyloxy)-9-bromo-4-methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione Properties: This compound is a complex organic molecule containing bromine, methyl, phenoxy, and multiple heterocyclic structures. It exhibits good thermal and chemical stability and is suitable for various organic synthesis reaction conditions. Storage Recommendations: Store in a sealed, light-proof, and dry place, subject to the specific requirements of the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial-scale production. We can provide small-scale preparation, pilot-scale amplification, and customized batch production according to customer needs. We also offer flexible supply solutions based on customer requirements for purity, impurity control, packaging specifications, delivery time, and quality documentation. Furthermore, we have a professional technical support team to assist customers in process development, route optimization, and project transformation, ensuring efficient and compliant project progress.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing a rich product line and accumulated technology. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting purity, impurity standards, and packaging according to customer requirements. Provides supporting process optimization and scale-up technologies to help customers achieve efficient commercialization and industrialization.
Intermediates of Dolutegravir
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1206102-10-4, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
